Admission Date:  [**2199-9-8**]     Discharge Date:  [**2199-9-13**]  Date of Birth:   [**2154-4-16**]     Sex:  F  Service:  Medicine  HISTORY OF PRESENT ILLNESS:  The patient is a 45 year old woman with nonsmall cell lung cancer with metastases to the brain and adrenals with a deep vein thrombosis in her right lower extremity, diagnosed on [**2199-8-16**], status post inferior vena cava filter placement and recent left lower extremity deep vein thrombosis, diagnosed on [**2199-9-6**], which has become increasingly painful.
She was admitted to the Medical Intensive Care Unit on [**2199-9-8**] for neurologic checks every hour while receiving heparin with known brain metastases and with recent craniotomy.
The decision had been made to put the patient on heparin due to perceived compromise of the limb secondary to phlegmasia dolens of the left lower extremity.
She is status post carboplatin and Taxol times two cycles, thoracic radiation therapy and taxotere.
She was subsequently treated with steroids and whole brain radiation.
Now she is status post craniotomy in [**2199-7-28**].
The surgery was complicated by a postoperative deep vein thrombosis in the right lower extremity, diagnosed on [**2199-8-16**] and an inferior vena cava filter was placed.
In the Emergency Room, the patient received heparin and was then transferred to the Medical Intensive Care Unit for hourly neurologic checks.
Right lower extremity deep vein thrombosis, status post inferior vena cava filter.
LABORATORY DATA:  White blood cell count was 14, hematocrit 23.7, platelet count 185,000, sodium 124, potassium 4.7, chloride 86, bicarbonate 22, BUN 21, creatinine 0.5, glucose 110, ALT 15, AST 16, alkaline phosphatase 715, total bilirubin 0.5, GGT 764, albumin 2.7, calcium 8.4, magnesium 2, phosphorous 4.7, SDP 40 to 80, d-dimer greater than 2,000, and fibrinogen 312.
HOSPITAL COURSE:  The patient was continued on a heparin sliding scale with a partial thromboplastin time goal of 50 to 70 once she was transferred to the floor.
The pain stayed fairly constant throughout her admission and the patient was started on a fentanyl patch with oxycodone for breakthrough pain.
On the day prior to discharge, the patient was started on Lovenox at a dose of 1 mg/kg twice a day, coming to 60 mg subcutaneously every 12 hours.
DISCHARGE MEDICATIONS: Bisacodyl 10 mg p.r.p.r.n.
Bisacodyl 5 mg p.o.p.r.n.
Dexamethasone 2 mg p.o.q.d.
Docusate sodium 100 mg p.o.b.i.d.p.r.n.
Enoxaparin 60 mg s.c.b.i.d.
Fentanyl patch 100 mcg transdermal q.72h.
Fluconazole 100 mg p.o.q.d.
Lorazepam 0.5 mg p.o.q.d.
Nystatin 5 ml p.o.q.i.d.
Oxycodone 5 mg p.o.q.4h.p.r.n.
Protonix 40 mg p.o.q.d.
Phenytoin 100 mg p.o.t.i.d.
Prochlorperazine 10 mg p.o.q.8h.p.r.n.
Sertraline 100 mg p.o.q.d.
She will continue to administer Lovenox injections at home.
